BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16923336)

  • 1. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
    Qin J; Liu ZX
    Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
    Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
    Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
    Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
    J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of antisense oligodeoxynucleotide to p44/p42 MAPK on angiotensin II-induced hypertrophic response in cultured neonatal rat cardiac myocyte.
    Zhang SQ; Ding B; Guo ZG; Li YX
    Acta Pharmacol Sin; 2004 Jan; 25(1):41-6. PubMed ID: 14704121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy.
    Hingtgen SD; Tian X; Yang J; Dunlay SM; Peek AS; Wu Y; Sharma RV; Engelhardt JF; Davisson RL
    Physiol Genomics; 2006 Aug; 26(3):180-91. PubMed ID: 16670255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of tetrandrine on Ang II-induced cardiomyocyte hypertrophy and p-ERK1/2 expression].
    Zhou DX; Yang GT; He XX; Liu Q
    Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1921-4. PubMed ID: 18051908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythropoietin inhibits angiotensin II induced cardiomyocyte hypertrophy in vitro via activating PI3K/Akt-eNOS pathway].
    Wen Y; Ma YX; Zhang XJ; Hong LF; Feng DY; Lu ZH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 May; 37(5):436-40. PubMed ID: 19781221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
    Li T; Wang Y; Liu C; Hu Y; Wu M; Li J; Guo L; Chen L; Chen Q; Ha T; Li C; Li Y
    J Hypertens; 2009 May; 27(5):1084-93. PubMed ID: 19342961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin II receptor 1 antisense oligodoexynucleotides on physiological and pathophysiological growth of cardiomyocytes.
    Wang Y; Wang JM; Yan SX; Li MJ; Li JJ
    Acta Pharmacol Sin; 2004 May; 25(5):561-9. PubMed ID: 15132819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
    Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
    Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of c-fos, c-jun mRNA expressions in cardiomyocyte hypertrophy induced by angiotensin II and effects of tanshinone II A].
    Zhou DX; Liang QS; He XX; Zhan CY
    Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(8):936-9. PubMed ID: 18619357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FAK related non-kinase (FRNK) inhibits migration of a human breast carcinoma cell line MDA-MB-435].
    Qin J; Liu ZX
    Ai Zheng; 2006 Jul; 25(7):833-8. PubMed ID: 16831273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
    Kilić A; Javadov S; Karmazyn M
    J Mol Cell Cardiol; 2009 Mar; 46(3):360-9. PubMed ID: 19111554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla.
    Chan SH; Wang LL; Tseng HL; Chan JY
    J Hypertens; 2007 Sep; 25(9):1845-61. PubMed ID: 17762649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes.
    Xu FP; Chen MS; Wang YZ; Yi Q; Lin SB; Chen AF; Luo JD
    Circulation; 2004 Sep; 110(10):1269-75. PubMed ID: 15313952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
    Ye P; Yang W; Wu SM; Sheng L
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.